Company / CapEx per Share
RECURSION PHARMACEUTICALS, INC. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.02 / $1.78
FY2021-FY2025
Trend
-72.1%
vs FY2024
Sector context
#111 of 192
Health Care
What the data says
At $0.02, RECURSION PHARMACEUTICALS, INC.'s capex per share ranks #111 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 7 years, ranging from $0.02 in FY2025 to $1.78 in FY2021.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -42.9%.
Declined from $0.06 to $0.02 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -21.9%
- 5-Year CAGR
- -42.9%
- 10-Year CAGR
- -
Sector benchmark
#111 of 192 in Health CareTop 58% of 192This company $0.02 Sector average $2.46
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 72.1% year-over-year.
- Ranks #111 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -72.1% |
| FY2024 | $0.06 | -6.6% |
| FY2023 | $0.06 | +82.8% |
| FY2022 | $0.03 | -98.1% |
| FY2021 | $1.78 | +566.2% |
| FY2020 | $0.27 | +47.7% |
| FY2019 | $0.18 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026